on GENOWAY (EPA:ALGEN)
Launch of genOway franchises in Canada and Australia
genOway, specializing in predictive preclinical solutions, announces the opening of its first franchises in Canada and Australia. This initiative is part of the ROUTE50+DATA strategic plan, which aims to reach €50 million in revenue by 2028. Dr. Nandita Noronha and Dr. Nathalie Taquet have been appointed the exclusive distributors in these respective countries.
The goal is to create ten franchises by 2026, leveraging local entrepreneurs to strengthen genOway's presence. The franchise network is expected to contribute 15% to projected revenue. This strategy is a key component for expanding the company into international markets.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all GENOWAY news